Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Fennec Pharmaceuticals Ownership Summary


Fennec Pharmaceuticals is owned by 15.27% institutional investors, 16.23% insiders, and 68.50% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 14.90% of FENC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.89% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFennec Pharmaceuticals15.27%16.23%68.50%
SectorHealthcare Stocks 57.47%9.40%33.13%
IndustryBiotech Stocks 69.06%8.93%22.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Southpoint capital advisors lp4.08M14.90%$25.77M
Sonic gp2.41M8.80%$15.21M
Solas capital management2.25M8.22%$14.23M
Rosalind advisors1.26M4.60%$7.96M
Blackrock funding, inc. /de1.23M4.48%$7.75M
Blackrock1.19M4.39%$7.25M
Dg capital management1.11M4.07%$7.04M
Vanguard group969.75K3.54%$6.13M
Harbert fund advisors466.87K1.71%$2.95M
State street339.71K1.24%$2.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp2.41M33.54%$15.21M
Solas capital management2.25M9.45%$14.23M
Lion point capital, lp195.70K6.48%$1.24M
Rosalind advisors1.26M4.07%$7.96M
Dg capital management1.11M2.37%$7.04M
Harbert fund advisors466.87K1.53%$2.95M
Southpoint capital advisors lp4.08M0.60%$25.77M
Clayton partners40.54K0.18%$256.21K
Hartford financial management49.85K0.06%$315.04K
Sherbrooke park advisers21.69K0.04%$137.07K

Top Buyers

HolderShares% AssetsChange
Rosalind advisors1.26M4.07%1.26M
Solas capital management2.25M9.45%327.38K
Blackrock1.19M0.00%259.78K
Clayton partners40.54K0.18%40.54K
Morgan stanley102.08K-28.00K

Top Sellers

HolderShares% AssetsChange
Aigh capital management---570.33K
Dg capital management1.11M2.37%-407.51K
Essex investment management---144.22K
Renaissance---139.90K
Vanguard group969.75K0.00%-78.14K

New Positions

HolderShares% AssetsChangeValue
Rosalind advisors1.26M4.07%1.26M$7.96M
Clayton partners40.54K0.18%40.54K$256.21K
Susquehanna group, llp12.43K-12.43K$78.57K
Intech investment management10.99K0.00%10.99K$69.44K
Eversource wealth advisors692.000.00%692.00$4.37K

Sold Out

HolderChange
Newedge advisors-1.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-5.00
Toronto dominion bank-25.00
Citadel advisors-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202431-50.00%4,180,599-72.00%150.51%23-30.30%4-73.33%
Sep 30, 202462-14,931,2843.97%541.93%33-19.51%1536.36%
Jun 30, 202462-7.46%14,360,529-0.88%531.82%4113.89%11-42.11%
Mar 31, 20246715.52%14,487,913-3.48%531.68%3624.14%1935.71%
Dec 31, 202358-1.69%15,010,9684.85%561.94%2945.00%14-17.65%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv793.42K2.89%-
iShares Russell 2000 ETF564.59K2.06%-11.07K
Fidelity Small Cap Index241.44K0.88%2.64K
iShares Russell 2000 Value ETF161.00K0.59%-330.00
State St Russell Sm/Mid Cp® Indx NL Cl C122.70K0.45%-
Vanguard Russell 2000 ETF104.96K0.38%-7.04K
State St Russell Sm Cap® Indx SL Cl I69.00K0.25%-
Schwab Small Cap Index61.15K0.22%-
iShares Micro-Cap ETF52.92K0.19%-
NT R2000 Index Fund - NL51.16K0.19%-6.29K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 05, 2025Raykov Rosty-Sell$67.90K
Feb 14, 2025RALLIS CHRIS A-Sell$8.09K
Feb 05, 2025Raykov Rosty-Sell$66.60K
Jan 06, 2025Raykov Rosty-Sell$46.02K
Jan 06, 2025Raykov Rosty-Sell$14.78K

Insider Transactions Trends


DateBuySell
2025 Q3--
2024 Q4-1
2024 Q3-4
2024 Q2218
2024 Q1-5

FENC Ownership FAQ


Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 15.27%, followed by 16.23% insiders and 68.50% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 69.06%, which Fennec Pharmaceuticals falls below.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 14.90%), Sonic gp (2.41M shares, 8.80%), and Solas capital management (2.25M shares, 8.22%). Together, they hold 31.92% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fennec Pharmaceuticals shares, with 2.89% of its total shares outstanding invested in 793.42K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools